Pharmaceuticals

SIGA Technologies SIGA Stock Price is on fire pre-market, can it go higher? URGENT

SIGA Technologies SIGA stock price is up 11% in the last 5 days & volume is up 230%, but is it over for this breakout stock?

There is an old adage, “two heads are better than one”, so let’s collaborate on ECTM and compare notes.

In this in depth report, I look at 5 KPIs: Technical Analysis, Volume, News Cycle, Fundamentals & awareness campaigns. I believe the stock market is not gambling, it is also not fool proof, but I have developed a dependable system. I have found some critical components to success for SIGA, tell me what you think.

Before we get started, I like being methodical and easy to understand so I have developed a ranking system for my stocks. I call it, Alexander Goldman’s “HOT Stock Ranking!”

CA:XBC stock price

The official heat level for SIGA is, a 🔥🔥🔥 3 out of 4

Before I get ahead of myself and just jump right into this exciting breakout stock, I wanted to introduce myself.

Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading small cap stocks, breakout stocks and trending stocks for 20 years now. I’m accredited for establishing the coveted HOT Stock Reporting system for breakout stocks.

To find out more about my story, CLICK HERE


[thrive_leads id=’28419′]

SIGA Technologies Company Information

Company Name: SIGA Technologies Inc.

Ticker: SIGA

Exchange: NASDAQ

Website: https://www.siga.com/

SIGA Technologies Company Summary:

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The firm develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY.

SIGA stock price is due to News?

May 25, 2022 (AB Digital via COMTEX) — The global biotechnology market is expected to grow at a compound annual growth rate of 15.83% from 2021 to 2028 to reach USD$2.4 trillion by 2028 according to Grand View Research.  The industry is on the upswing and several stocks in the sector require your immediate attention.

SIGA Stock Price

SIGA Stock Price HOT Stock Grade:

The official heat level for SIGA is, a 🔥🔥🔥 3 out of 4 . Here are my takeaways on it and why it is just a 3 out of 4. Do you agree?

SIGA Trading Volume

The volume, is trading at an increase of 230% over the average which indicates a higher demand in the stock.

Trading 101: volume is measured in the number of shares traded. Traders look to volume to determine liquidity and combine changes in volume with technical indicators to make trading decisions. So, let’s take a look at the technical indicators.

SIGA Technicals

The technical analysis “chart reading”, it is bullish and has been that way since the early part of this month with a steady ascending channel until it went up over 200% and pulled back. Is this a breakout from the pullback pattern? It appears so, but I would wait till the rush is over this morning before considering a position.

More than likely it will pullback after this pre-market rush.

Trading 101: Technical indicators are technical tools that help in analyzing the movement in the stock prices whether the ongoing trend is going to continue or reverse. It helps the traders to make entry and exit decisions of a particular stock. Technical indicators can be leading or lagging indicators.

SIGA News Cycle

The news, there is significant news: “is expected to grow at a compound annual growth rate of 15.83% from 2021 to 2028 to reach USD$2.4 trillion by 2028”

ECTM Fundamentals

The fundamentals, there is exciting financial filings associated with this stock, “374% growth combined over last two years”!

Trading 101: Fundamental trading is a method where a trader focuses on company-specific events to determine which stock to buy and when to buy it. Trading on fundamentals is more closely associated with a buy-and-hold strategy rather than short-term trading.

SIGA Awareness

Marketing efforts “Awareness Campaigns”, I have not found marketing efforts around the investor awareness of this company. Hence the 3 out of 4. Do you agree? Write me a line at [email protected]

Again, two heads are better than one, let’s work together to have the best trading year of our lives!

To receive my 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

To find out more about my story, CLICK HERE

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥 HOT stocks and we can compare notes!👇


[thrive_leads id=’28419′]

read more

TC BioPharm TCBP Stock Price broke out, the set up is AMAZING! Pay ATTENTION!

TC BioPharm TCBP stock price is up today & volume is up 8%, this appears to be the bottom I have been waiting for. I am consequently, placing an immediate and elusive 4🔥 official heat level for TC BioPharm TCBP is, that is a 🔥🔥🔥 4 out of 4!

There is an old adage, “two heads are better than one”, so let’s collaborate on TCBP and compare notes.

In this in depth report, I look at 5 KPIs: Technical Analysis, Volume, News Cycle, Fundamentals & awareness campaigns. I believe the stock market is not gambling, it is also not fool proof, but I have developed a dependable system. I have found some critical components to success for TCBP, tell me what you think.

Before we get started, I like being methodical and easy to understand so I have developed a ranking system for my stocks. I call it, Alexander Goldman’s “HOT Stock Ranking!”

CA:XBC stock price

The official heat level for TCBP is, a 🔥🔥🔥🔥 4 out of 4

Before I get ahead of myself and just jump right into this exciting breakout stock, I wanted to introduce myself.

Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading small cap stocks, breakout stocks and trending stocks for 20 years now. I’m accredited for establishing the coveted HOT Stock Reporting system for breakout stocks.

To find out more about my story, CLICK HERE


[thrive_leads id=’28419′]

TC BioPharm Company Information

Company Name: TC BioPharm Inc.

Ticker: TCBP

Exchange: NASDAQ

Website: https://www.tcbiopharm.com/

TC BioPharm Company Summary:

TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel immunotherapy products based on its proprietary allogeneic gamma delta T cell platform. The company was founded by Michael Leek and Angela Scott in 2013 and is headquartered in Motherwell, the United Kingdom.

TCBP stock price is due to News?

April 6, 2022

Announced that it has successfully registered the UK trademark “CryoTC®”, for the Company’s proprietary process for freezing and thawing of its lead oncology product, OmnImmune®.

CryoTR® is TC BioPharm’s unique process of cryopreservation, which is performed in a controlled rate freezer using an optimized protocol. OmnImmune® is an allogeneic unmodified cell therapy consisting of activated and expanded gamma delta T cells. OmnImmune® comprises GDT cells sourced from healthy donors, activated and expanded in large numbers before being purified formulated, and cryopreserved for subsequent thawing and infusion into patients. 

TCBP stock Price

TCBP Stock Price HOT Stock Grade:

The official heat level for ECTM is, a 🔥🔥🔥🔥 4 out of 4 . Here are my takeaways on it and why it is just a 3 out of 4. Do you agree?

TCBP Trading Volume

The volume, is trading at an increase of 8% over the average which indicates a higher demand in the stock. This is a great sign that trading activity is picking up, but we also don’t want to see 100%, 200% or even 400% increases in volume because that would mean the short term move is over.

I pride myself in determining moves before they happen! I believe, this may be the very situation wee are witnessing right now with TC BioPharm NASDAQ:TCBP. Pay attention!

Trading 101: volume is measured in the number of shares traded. Traders look to volume to determine liquidity and combine changes in volume with technical indicators to make trading decisions. So, let’s take a look at the technical indicators.

TCBP Technicals

The technical analysis “chart reading”, it is consolidated after a bearish move and now has broken out of the consolidation as you can see from the chart below.

TCBP

That tap at $1.00 was significant as well as the resistance point at $.95 that was broken and is holding. Hence I am placing TCBP on an immediate 4 out 4 alert!

Trading 101: Technical indicators are technical tools that help in analyzing the movement in the stock prices whether the ongoing trend is going to continue or reverse. It helps the traders to make entry and exit decisions of a particular stock. Technical indicators can be leading or lagging indicators.

TCBP News Cycle

The news, there is significant news. The news, “Announced that it has successfully registered the UK trademark “CryoTC®”, for the Company’s proprietary process for freezing and thawing of its lead oncology product, OmnImmune®.” is huge! Cancer will be a $268 BILLION dollar industry by 2026. HERE

TCBP Fundamentals

The fundamentals, there is exciting financial filings associated with this stock, “265% growth”!

As you can see from the above screen shot from Market Watch HERE

The EBITDA has grown at 18%, that is STRONG!

Trading 101: Fundamental trading is a method where a trader focuses on company-specific events to determine which stock to buy and when to buy it. Trading on fundamentals is more closely associated with a buy-and-hold strategy rather than short-term trading.

TCBP Awareness

Marketing efforts “Awareness Campaigns”, I have found marketing efforts around the investor awareness of this company. Hence the 4 out of 4. Do you agree? Write me a line at [email protected]

Again, two heads are better than one, let’s work together to have the best trading year of our lives!

To receive my 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

To find out more about my story, CLICK HERE

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥 HOT stocks and we can compare notes!👇


[thrive_leads id=’28419′]

Small Cap Exclusive is owned and operated by JBN PARTNERS LLC, which is a US based corporation. We have been compensated $4,000 for profiling TCBP. We own ZERO shares in TCBP. We are paid advertisers, also known as stock touts or stock promoters, who disseminate favorable information (this “Article”) about publicly traded companies (the “Profiled Issuers”).

Full Disclaimer

read more

PTPI Stock Price has plummeted, is it ready to bounce? URGENT

Petros Pharmaceuticals PTPI stock price is down –4% in the last 5 days & volume is up 7%, but is it over for this breakout stock?

In this in depth report, I look at 5 KPIs: Technical Analysis, Volume, News Cycle, Fundamentals & awareness campaigns.

Before we get started, I like being methodical and easy to understand so I have developed a ranking system for my stocks. I call it, Alexander Goldman’s “HOT Stock Ranking!”

CA:XBC stock price

The official heat level for PTPI is, a 🔥🔥2 out of 4

Before I get ahead of myself and just jump right into this exciting breakout stock, I wanted to introduce myself.

Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading small cap stocks, breakout stocks and trending stocks for 20 years now. I established the coveted HOT Stock Reporting system.

To find out more about my story, CLICK HERE


[thrive_leads id=’28419′]

Petros Pharmaceuticals Company Information

Company Name: Petros Pharmaceuticals Inc

Ticker: PTPI

Exchange: NASDAQ

Website: https://www.petrospharma.com/

Petros Pharmaceuticals Company Summary:

Petros Pharmaceuticals, Inc. engages in men’s health therapeutics. It is involved in sales, marketing, regulatory and medical affairs, finance, trade relations, pharmacovigilance, market access relations, manufacturing, and distribution. It operates through the Prescription Medications and Medical Devices segments. The Prescription Medications segment handles Stendra, a FDA approved PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction, and H100, a topical formulation candidate for the treatment of acute Peyronie’s disease. The Medical Devices segment consists of vacuum erection devices. The company was founded on May 14, 2020 and is headquartered in New York, NY.EBML stock price is due to News?

PTPI stock price is due to News?

  • Announced the pursuit of the 505(b)(2) pathway for early stage asset, H-100 for the treatment of Peyronie’s Disease
  • Initiated sponsored research agreement with Massachusetts General Hospital to evaluate incorporating the use of a tissue-specific oxygenation sensor with the goal of monitoring and understanding the success of Erectile Device Therapy.
  • Reported positive results of a Phase 2 label comprehension study to initiate process for STENDRA(R) prescription erectile dysfunction medication to support the process for designation as over -the-counter treatment
  • Engaged with celebrity physician, Dr. Drew Pinsky to provide patient education about erectile dysfunction and branded STENDRA messaging
  • Announced an agreement with a leading U.S. based global contract manufacturer for STENDRA

PTPI

PTPI Stock Price HOT Stock Grade:

PTPI is, a 🔥🔥2 out of 4 . Here are my takeaways on it and why it is just a 3 out of 4.

PTPI Trading Volume

The volume, the normal trading volume is established by the previous 30 days of trading and this stock is trading at an increase of 7% over the average. Normally, this indicates a higher demand in the stock or a sell off (selling pressure).

Trading 101: volume is measured in the number of shares traded. Traders look to volume to determine liquidity and combine changes in volume with technical indicators to make trading decisions. So, let’s take a look at the technical indicators.

PTPI Technicals

The technical analysis “chart reading”, this stock is down -3% on the 5 day chart and the overall trend for the long term chart, the 1 month, is down -31%. We are still waiting for the bottom. I imagine good news should be coming soon, pay attention and bookmark it.

Trading 101: Technical indicators are technical tools that help in analyzing the movement in the stock prices whether the ongoing trend is going to continue or reverse. It helps the traders to make entry and exit decisions of a particular stock. Technical indicators can be leading or lagging indicators.

PTPI News Cycle

The news, there is no significant news.

PTPI Fundamentals

The fundamentals, how a company is doing financially can be a serious KPI and there is no exciting financial filings associated with this stock.

Trading 101: Fundamental trading is a method where a trader focuses on company-specific events to determine which stock to buy and when to buy it. Trading on fundamentals is more closely associated with a buy-and-hold strategy rather than short-term trading.

PTPI Awareness

Marketing efforts “Awareness Campaigns” Just like advertising a prroduct is important, advertising a publicly traded company during a news cycle is critical for the stock price of a company.

I have found marketing efforts around the investor awareness of this company. So, I have awarded this stock a 2 out of 4. Do you agree? Write me a line at [email protected]

Again, two heads are better than one, let’s work together to have the best trading year of our lives!

To receive my 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

To find out more about my story, CLICK HERE

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥 HOT stocks and we can compare notes!👇


[thrive_leads id=’28419′]

read more

Ocular Therapeutix OCUL Stock Price is down 21%, can it go recover? URGENT REPORT

Ocular Therapeutix OCUL stock price is down -21% in the last 5 days & volume is up over 500%, but can it bounce?

In this in depth report, I look at 5 KPIs: Technical Analysis, Volume, News Cycle, Fundamentals & awareness campaigns.

Before we get started, I like being methodical and easy to understand so I have developed a ranking system for my stocks. I call it, Alexander Goldman’s “HOT Stock Ranking!”

CA:XBC stock price

The official heat level for OCUL is, a 🔥1 out of 4

Before I get ahead of myself and just jump right into this exciting breakout stock, I wanted to introduce myself.

Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading small cap stocks, breakout stocks and trending stocks for 20 years now. I established the coveted HOT Stock Reporting system.

To find out more about my story, CLICK HERE


[thrive_leads id=’28419′]

Ocular Therapeutix Company Information

Company Name: Ocular Therapeutix Inc.

Ticker: OCUL

Exchange: NASDAQ

Website: https://www.ocutx.com/

Ocular Therapeutix Company Summary:

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

OCUL stock price is due to News?

The U.S. Commercial Uptake of DEXTENZA.

  • Net product revenue of DEXTENZA® for the quarter was $12.5 million, an 87% increase over the first quarter of 2021.
  • In-market purchases were nearly 28,000 billable units for the quarter, with March accounting for approximately 10,500 billable units, setting a new record for a calendar month.

Compare Ocular Therapeutix OCUL stock Price vs Competitors

KalVista Pharmaceuticals KAVL HERE

Anika Therapeutics ANIK HERE

OCUL

OCUL Stock Price HOT Stock Grade:

OCUL is, a 🔥1 out of 4 . Here are my takeaways on it and why it is just a 1 out of 4. Hint, the financials are great and the news but it’s still a 1 of 4 because the chart is my primary KPI.

OCUL Trading Volume

The volume, the normal trading volume is established by the previous 30 days of trading and this stock is trading at an increase of 502% over the average. Normally, this indicates a higher demand in the stock or a sell off (selling pressure).

Trading 101: volume is measured in the number of shares traded. Traders look to volume to determine liquidity and combine changes in volume with technical indicators to make trading decisions. So, let’s take a look at the technical indicators.

OCUL Technicals

The technical analysis “chart reading”, this stock is down 22% on the 5 day chart and the overall trend for the long term chart, the 1 month, is down 31%. INSERT ANNALYSIS

Trading 101: Technical indicators are technical tools that help in analyzing the movement in the stock prices whether the ongoing trend is going to continue or reverse. It helps the traders to make entry and exit decisions of a particular stock. Technical indicators can be leading or lagging indicators.

OCUL News Cycle

The news, there is significant news, “Net product revenue of DEXTENZA® for the quarter was $12.5 million, an 87% increase over the first quarter of 2021.”

OCUL Fundamentals

The fundamentals, how a company is doing financially can be a serious KPI and there is no exciting financial filings associated with this stock.

Trading 101: Fundamental trading is a method where a trader focuses on company-specific events to determine which stock to buy and when to buy it. Trading on fundamentals is more closely associated with a buy-and-hold strategy rather than short-term trading.

OCUL Awareness

Marketing efforts “Awareness Campaigns” Just like advertising a prroduct is important, advertising a publicly traded company during a news cycle is critical for the stock price of a company.

I have not found marketing efforts around the investor awareness of this company. So, I have awarded this stock a 1 out of 4. Do you agree? Write me a line at [email protected]

Again, two heads are better than one, let’s work together to have the best trading year of our lives!

To receive my 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

To find out more about my story, CLICK HERE

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥 HOT stocks and we can compare notes!👇


[thrive_leads id=’28419′]

read more

Hillstream BioPharma HILS Stock Price is consolidated and ready for a run? Urgent REPORT

HILS Stock Price has been trying to recover since it’s February high of $4.

Wondering why this stock is having such a hard time and if it can break the overall trend?

Before we do, remember to stop what you are doing and 👇 Sign up for our newsletter to get the latest breakout stocks and trending stocks!


[thrive_leads id=’14274′]

Before we get started, I wanted to introduce myself to you. Hi 🙋‍♂️ I’m Alexander Goldman and I have been successfully trading breakout stocks and trending stocks for two decades now.

I’m now helping traders find breakout stocks. My claim to fame is the expert at finding trending stocks.

What do I mean by big winners?

Stocks that move more than 100% in a month! HILS Stock Price could?

Does that always happen, NO! But, I’m very good! Take a look at this article I wrote, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!

The article is HERE where I shine a spotlight on trending stocks and breakout stocks!

Now, let’s go over some of the basic information on this stock before we get in the technical analysis

Hillstream BioPharma Company Information

Company Name: Hillstream BioPharma Inc

Ticker: HILS

Exchange: NASDAQ

Website: https://hillstreambio.com/

Hillstream BioPharma Company Summary:

Hillstream BioPharma, Inc. is a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death (IMCD) for drug resistant and devastating cancers.

It also develops the Trident Artificial Intelligence (TAI) precision medicine platform which is used to identify biomarkers in its clinical programs to target a specific patient segment. The company was founded on March 28, 2017 and is headquartered in Bridgewater, NJ.

HILS stock price is due to News?

Mar 02, 2022 (GLOBE NEWSWIRE via COMTEX) — BRIDGEWATER, NJ, March 02, 2022 (GLOBE NEWSWIRE) — Hillstream BioPharma, Inc. (NASDAQ: HILS) (“Hillstream” or the “Company”), a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death for drug resistant and devastating cancers, provided a webcast replay of the Company’s R&D Day held on February 24, 2022.

HILS 5 Day Chart

HILS stock price

HILS Stock Price Technical Analysis:

I like this stock a lot from the technical side. There is an upside of $4 and that is 100% gain. I believe there will be some consolidation and a pullback then a run. So be patient and timing is everything.

This is Alex, reminding all the traders out there to leave your emotions at the door and never, ever, try to catch a falling knife. I strive to find breakout stock alerts and deliver them before the market finds out. I sure hope you enjoyed this article, if you would like to receive more exclusive content from me 👇 sign up for our newsletter below. 👇


[thrive_leads id=’14274′]

read more

LIXT Stock Price has consolidated and could be ready for a run? URGENT URGENT

Lixte Biotechnology Holdings Inc. LIXT stock price is finally showing some life as it reverses trend. LIXT is up 33% in the last 5 days and I will be evaluating many factors to determine just how hot the stock is.

The official heat level for LIXT is, a 🔥🔥🔥 3 out of 5.

LIXT stock price

Continue reading to see why I think it is just a 3 out of 5. There is some shocking takeaways from this article that you must read if you are interested in LIXT.

If you are interested in finding out more about me, famed stock picker, Alexander Goldman or if you’re interested in my HOT grading system, sign up today, it’s FREE!

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥🔥 HOT stocks and trending stocks!👇 In fact, I will send you personally a 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter.


[thrive_leads id=’14274′]

Before I go over this exciting trending stock, I wanted to introduce myself. Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading, at a very high level, breakout stocks and trending stocks for 20 years now. I’m accredited for establishing the coveted HOT grading system for trending stocks.

I found my home at Small Cap exclusive 4 years ago. Now, I’m helping traders find breakout stocks. Not to sound egotistical but I’m very good at finding small cap stocks that are winners.

What do I mean by big winners?

Stocks that move more than 100% in a month! LIXT Stock Price could?

Does that always happen, NO! But, I’m very consistent! Take a look at this article I wrote below, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!

The article is HERE and I shine a spotlight on these breakout stocks and also those losers!

Now, let’s go over some of the basic information on this stock before we get in the technical analysis and how I came up with HOT grade.

Lixte Biotechnology Holdings Company Information

Company Name: Lixte Biotechnology Holdings

Ticker: LIXT

Exchange: NASDAQ

Website: https://lixte.com/

Breakout Stock Lixte Biotechnology Holdings Company Summary:

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company, that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The firm focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development.

It develops two series of pharmacologically active drugs, which include the LB-100 series that consists of novel structures, which might be useful in the treatment of cancers, and vascular and metabolic diseases; and LB-200 series for the treatment of chronic hereditary diseases, such as Gaucher’s disease, as well as cancer and neurodegenerative diseases. The company was founded by John S. Kovach and Robert B. Royds on August 9, 2005 and is headquartered in East Setauket, NY.

LIXT stock price is due to News?

January 12, 2022

Has led to an initial joint patent application covering LB-100 combination therapy with one of several other investigational compounds. The Company, NKI and Oncode Institute believe that the combination therapy would provide unexpectedly strong synergistic anti-cancer effects in cancer patients. The Company previously announced its entry into a collaboration with the NKI and the Oncode Institute to identify the most promising drugs to be used in combination with the Company’s LB-100 or with one of the Company’s LB-100 analogues to treat a range of cancers, as well as to identify the specific molecular mechanisms underlying the identified combinations.

LIXT stock price

LIXT Stock Price HOT Stock Grade:

The official heat level for SMCE is, a 🔥🔥🔥3 out of 5 . Continue reading to see why I think it is just a 3 out of 5. Here are my takeaways on LIXT and why it is just a 3 out of 5.

The volume, which is basically demand of a stock is incredible due to the news lately. They filed a 10K today

The news, the 10K had plenty of positive news

The chart, it is consolidating and that is why it is not a 4 out of 5

The fundamentals, are strong but lack the profit margins I normally would like to see. Hence not a 5 out of 5

Marketing efforts, I have found marketing efforts around the investor awareness of this company which saved it from a 2 out of 5 rating.

To receive my 🔥🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥🔥 HOT stocks and trending stocks!👇


[thrive_leads id=’14274′]

read more

CRXT Stock Price is ready for more gains? URGENT Report

Clarus Therapeutics Holdings Inc. CRXT Stock Price has been trying to recover since it’s IPO high of almost $10. Wondering why this stock is having such a hard time and if it can break the overall trend?

Before we do, remember to stop what you are doing and 👇 Sign up for our newsletter to get the latest breakout stocks and trending stocks!


[thrive_leads id=’14274′]

Before we get started, I wanted to introduce myself to you. Hi 🙋‍♂️ I’m Alexander Goldman and I have been successfully trading breakout stocks and trending stocks for two decades now.

I’m now helping traders find breakout stocks. My claim to fame is the expert at finding trending stocks.

What do I mean by big winners?

Stocks that move more than 100% in a month! CRXT Stock Price could?

Does that always happen, NO! But, I’m very good! Take a look at this article I wrote, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!

The article is HERE where I shine a spotlight on trending stocks and breakout stocks!

Now, let’s go over some of the basic information on this stock before we get in the technical analysis

Clarus Therapeutics Holdings Inc. Company Information

Company Name: Clarus Therapeutics Holdings Inc.

Ticker: CRXT

Exchange: NASDAQ

Website: https://clarustherapeutics.com/

Clarus Therapeutics Holdings Company Summary:

Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. the company’s first commercial product is JATENZO. It is headquartered in Northbrook, IL.

Clarus Therapeutics stock price is due to News?

March 16, 2022 (GLOBE NEWSWIRE) — Clarus Therapeutics Holdings, Inc. (Clarus) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, today announced the initiation of screening for the first patient in an investigator-initiated Phase 4 clinical trial designed to evaluate the efficacy and safety of JATENZO (testosterone undecanoate) oral softgel capsules for the treatment of adult hypogonadal men with chronic kidney disease (CKD). Clarus expects to announce results from the trial in the first half of 2023.

CRXT 5 Day Chart

CRXT stock price

CRXT Stock Price Technical Analysis:

Let’s go over 4 critical factors in regards to a trending stock.

The volume, which is basically demand of a stock is not consistent! However, due to the news, it is heavily traded.

The news, is about as good as you can get!

The chart, it WAS bullish but it went up 85% in today and is now pulling back.

The fundamentals, the vertical is a very profitable one!

I believe Clarus Therapeutics stock could be a good one but not right now. I’m putting it on my watchlist and getting familiar with it, waiting for the right time. After this pullback it will consolidate and I will be watching it!

Sign up for our newsletter 👇👇👇 to get the latest HOT stocks and trending stocks!


[thrive_leads id=’14274′]

read more

NRSN Stock Price has consolidated and could be ready for a run? URGENT Report

NeuroSense Therapeutics Ltd. NRSN stock price is finally showing some life as it reverses trend. NRSN is up 428% in the last 5 days and I will be evaluating many factors to determine just how HOT, the stock NSRN is.

The official HOT level for NRSN is, a 🔥🔥🔥 3 out of 5.

Continue reading to see why I think it is just a 3 out of 5. There is some shocking takeaways from this article that you must read if you are interested in SMCE.

If you are interested in finding out more about me, famed stock picker, Alexander Goldman or if you’re interested in my HOT grading system, sign up today, it’s FREE!

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥🔥 HOT stocks and trending stocks!👇 In fact, I will send you personally a 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter.


[thrive_leads id=’14274′]

Before I go over this exciting trending stock, I wanted to introduce myself. Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading, at a very high level, breakout stocks and trending stocks for 20 years now. I’m accredited for establishing the coveted HOT grading system for trending stocks.

I found my home at Small Cap exclusive 4 years ago. Now, I’m helping traders find breakout stocks. Not to sound egotistical but I’m very good at finding small cap stocks that are winners.

What do I mean by big winners?

Stocks that move more than 100% in a month! NRSN Stock Price could?

Does that always happen, NO! But, I’m very consistent! Take a look at this article I wrote below, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!

The article is HERE and I shine a spotlight on these breakout stocks and also those losers!

Now, let’s go over some of the basic information on this stock before we get in the technical analysis and how I came up with HOT grade.

NeuroSense Therapeutics Ltd. Company Information

Company Name: NeuroSense Therapeutics Ltd.

Ticker: NRSN

Exchange: NASDAQ

Website: https://www.neurosense-tx.com/

Breakout Stock NeuroSense Therapeutics Ltd. Company Summary:

Neurosense Therapeutics Ltd. operates as a clinical stage drug development company. It offers ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases. The company was founded by Alon Ben-Noon in February 2017 and is headquartered in Herzeliya, Israel.

NRSN stock price is due to News?

March 21, 2022 /PRNewswire via COMTEX/ — CAMBRIDGE, Mass., March 21, 2022 /PRNewswire/ — NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) (“NeuroSense”), a company developing treatments for severe neurodegenerative diseases, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to initiate a pharmacokinetic study of PrimeC in healthy adult subjects.

PrimeC is a novel extended-release oral formulation composed of a unique fixed-dose combination of two FDA-approved drugs: ciprofloxacin and celecoxib. PrimeC is designed to synergistically target several key mechanisms of amyotrophic lateral sclerosis (ALS) that contribute to motor neuron degeneration, inflammation, iron accumulation and impaired RNA regulation to potentially inhibit the progression of ALS.

NRSN stock price

NRSN Stock Price HOT Stock Grade:

The official heat level for SMCE is, a 🔥🔥 3 out of 5 . Continue reading to see why I think it is just a 3 out of 5. Here are my takeaways on SMCE and why it is just a 2 out of 5.

The volume, which is basically demand of a stock is fantastic!

The news, is about as good as you can get!

The chart, it WAS bullish but it went up 400% today and that is too much for me.

The fundamentals, the vertical is a very profitable one!

Marketing efforts, I have not found a significant awareness campaign running. Furthermore, with news like this, there should be an effort to disseminate the important news to investors.

To receive my 🔥🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥🔥 HOT stocks and trending stocks!👇


[thrive_leads id=’14274′]

read more

RCEL the best stock to buy? Trending stock? Breakout stock? Urgent Update

Avita Medical Inc. the best stock to buy? Trending stock? Breakout stock? Is ANPC the best stock to buy because it has been breaking it’s trend with large volume and a 13% change in PPS in 5 days. Wondering why this stock is taking off, take a look below. Before we do, remember to stop what you are doing and 👇 sign up for our newsletter below. 👇


[thrive_leads id=’14274′]

Before we get started, I wanted to introduce myself to you. Hi 🙋‍♂️ I’m Alexander Goldman and I have been successfully trading breakout stocks and trending stocks for two decades now.

I’m now helping traders find breakout stocks. My claim to fame is the expert at finding trending stocks.

What do I mean by big winners?

Stocks that move more than 100% in a month! RCEL Stock Price could?

Does that always happen, NO! But, I’m very good! Take a look at this article I wrote, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!

The article is HERE where I shine a spotlight on trending stocks and breakout stocks!

Now, let’s go over if RCEL is the best stock to buy? Below, is some of the basic information on this stock before we get in the technical analysis

Avita Medical Inc. Company Information

Company Name: Avita Medical Inc.

Ticker: RCEL

Exchange: NASDAQ

Website: https://avitamedical.com/

Avita Medical Inc. Summary:

AVITA Medical is a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration. AVITA Medical is advancing the standard of care for burn patients with its novel technology platform, the RECELL® System.

Our proprietary technology provides innovative treatment solutions derived from the skin’s own regenerative properties. The medical device works by preparing Spray-On Skin™ Cells, an autologous suspension comprised of the patient’s skin cells necessary to regenerate natural healthy epidermis. This autologous suspension is then sprayed onto the areas of the patient requiring treatment. RCEL the best stock to buy? Trending stock? Breakout stock?

RCEL the best stock to buy? Let’s look at the News

Mar 02, 2022

Announced today that they have been awarded a group purchasing agreement with Premier, Inc. The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the RECELL(R) System for the treatment of adult and pediatric patients that require treatment for severe burns. The RECELL(R) System is a device that enables healthcare professionals to produce a suspension of Spray-On Skin(TM) Cells using a small sample of the patient’s own skin for the treatment of acute thermal burns.

RCEL 5 Day Chart

RCEL

I love this stock! The news is great and the chart has consolidated after the run and I believe it will run again SOON!

I hope I did a good job with my analysis of RCEL and if it is the best stock to buy?

This is Alex, reminding all the traders out there to leave your emotions at the door and never, ever, try to catch a falling knife. I strive to find breakout stock alerts and deliver them before the market finds out. I sure hope you enjoyed this article, if you would like to receive more exclusive content from me 👇 sign up for our newsletter below. 👇


[thrive_leads id=’14274′]

read more